328 related articles for article (PubMed ID: 31419444)
1. Silica-coated iron oxide nanoparticles as a novel nano-radiosensitizer for electron therapy.
Fathy MM; Fahmy HM; Saad OA; Elshemey WM
Life Sci; 2019 Oct; 234():116756. PubMed ID: 31419444
[TBL] [Abstract][Full Text] [Related]
2. Dose-enhancement of MCF 7 cell line radiotherapy using silica-iron oxide nanocomposite.
Fathy MM; Saad OA; Elshemey WM; Fahmy HM
Biochem Biophys Res Commun; 2022 Dec; 632():100-106. PubMed ID: 36206593
[TBL] [Abstract][Full Text] [Related]
3. The effect of SiO
Darfarin G; Salehi R; Alizadeh E; Nasiri Motlagh B; Akbarzadeh A; Farajollahi A
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):836-846. PubMed ID: 29741418
[TBL] [Abstract][Full Text] [Related]
4. Application of dextran-coated iron oxide nanoparticles in enhancing the radiosensitivity of cancerous cells in radiotherapy with high-energy electron beams.
Rezaei M; Khoshgard K; Hosseinzadeh L; Haghparast A; Eivazi MT
J Cancer Res Ther; 2019; 15(6):1352-1358. PubMed ID: 31898672
[TBL] [Abstract][Full Text] [Related]
5. Radiation dose rate affects the radiosensitization of MCF-7 and HeLa cell lines to X-rays induced by dextran-coated iron oxide nanoparticles.
Khoshgard K; Kiani P; Haghparast A; Hosseinzadeh L; Eivazi MT
Int J Radiat Biol; 2017 Aug; 93(8):757-763. PubMed ID: 28452253
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy.
Klein S; Sommer A; Distel LV; Hazemann JL; Kröner W; Neuhuber W; Müller P; Proux O; Kryschi C
J Phys Chem B; 2014 Jun; 118(23):6159-66. PubMed ID: 24827589
[TBL] [Abstract][Full Text] [Related]
7. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells.
Baber O; Jang M; Barber D; Powers K
Inhal Toxicol; 2011 Aug; 23(9):532-43. PubMed ID: 21819260
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake, genotoxicity and cytotoxicity of cobalt ferrite magnetic nanoparticles in human breast cells.
Aşık E; Akpınar Y; Güray NT; İşcan M; Demircigil GÇ; Volkan M
Toxicol Res (Camb); 2016 Nov; 5(6):1649-1662. PubMed ID: 30090464
[TBL] [Abstract][Full Text] [Related]
9. Improving antiproliferative effect of the anticancer drug cytarabine on human promyelocytic leukemia cells by coating on Fe3O4@SiO2 nanoparticles.
Shahabadi N; Falsafi M; Mansouri K
Colloids Surf B Biointerfaces; 2016 May; 141():213-222. PubMed ID: 26852105
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies.
Askar MA; El Shawi OE; Abou Zaid OAR; Mansour NA; Hanafy AM
Tumour Biol; 2021; 43(1):225-247. PubMed ID: 34542050
[TBL] [Abstract][Full Text] [Related]
11. The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies.
Khoei S; Mahdavi SR; Fakhimikabir H; Shakeri-Zadeh A; Hashemian A
Int J Radiat Biol; 2014 May; 90(5):351-6. PubMed ID: 24475739
[TBL] [Abstract][Full Text] [Related]
12. Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy.
Detappe A; Kunjachan S; Sancey L; Motto-Ros V; Biancur D; Drane P; Guieze R; Makrigiorgos GM; Tillement O; Langer R; Berbeco R
J Control Release; 2016 Sep; 238():103-113. PubMed ID: 27423325
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the effect of 4MeV electron beam using gold nanoparticles in breast cancer cells.
Mehrnia SS; Hashemi B; Mowla SJ; Arbabi A
Phys Med; 2017 Mar; 35():18-24. PubMed ID: 28285936
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis, characterization of magnetic iron oxide nanoparticles and evaluations of the cytotoxicity and DNA damage of human breast carcinoma cell lines.
Sulaiman GM; Tawfeeq AT; Naji AS
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1215-1229. PubMed ID: 28826240
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of small-sized, porous, and low-toxic magnetite nanoparticles by thin POSS silica coating.
Yen SK; Varma DP; Guo WM; Ho VH; Vijayaragavan V; Padmanabhan P; Bhakoo K; Selvan ST
Chemistry; 2015 Mar; 21(10):3914-8. PubMed ID: 25630810
[TBL] [Abstract][Full Text] [Related]
16. Mg
Meidanchi A
Nanotechnology; 2020 Aug; 31(32):325706. PubMed ID: 32330910
[TBL] [Abstract][Full Text] [Related]
17. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of magnetofection efficiency using chitosan coated superparamagnetic iron oxide nanoparticles and calf thymus DNA.
Sohrabijam Z; Saeidifar M; Zamanian A
Colloids Surf B Biointerfaces; 2017 Apr; 152():169-175. PubMed ID: 28110038
[TBL] [Abstract][Full Text] [Related]
19. Iron-oxide nanoparticles target intracellular HSP90 to induce tumor radio-sensitization.
Shetake NG; Kumar A; Pandey BN
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):857-869. PubMed ID: 30794824
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies of the role of iron oxide magnetic nanoparticles for nonpalpable lesion localization in breast cancer.
Ahmed M; de Rosales RT; Douek M
J Surg Res; 2013 Nov; 185(1):27-35. PubMed ID: 23831229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
